Elevated levels of serum urokinase plasminogen activator predict poor prognosis in hepatocellular carcinoma after resection

BACKGROUND: Urokinase plasminogen activator (uPA) is an extracellular matrix-degrading protease that is involved in the invasiveness and progression of cancer. There is good evidence that uPA expression is a clinically relevant biomarker in some solid tumors, but its role in hepatocellulcar carcinom...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsai, Ming-Chao, Yen, Yi-Hao, Chang, Kuo-Chin, Hung, Chao-Hung, Chen, Chien-Hung, Lin, Ming-Tsung, Hu, Tsung-Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6889356/
https://www.ncbi.nlm.nih.gov/pubmed/31791275
http://dx.doi.org/10.1186/s12885-019-6397-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6889356/
https://www.ncbi.nlm.nih.gov/pubmed/31791275
http://dx.doi.org/10.1186/s12885-019-6397-3

Ejemplares similares